IMU hasn't released any negative clinical trial updates to date and if there's serious problem with the clinical trials then they wouldn't be escalating dosage but instead stopped them. Potentially these SD from the CCA expansion with a majority of them only 12 months into the clinical trial will eventually be classified as CR or PR in the next 3 months (6 months after the last data).
IMU Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)